Dr. Gaurav Mehta, Ph.D.

PhD Scientist with 13+ years of research experience in cancer biology, cell and molecular biology, genomics, metabolomics, and epigenetics

Research Interests

Molecular Biology
Epigenetics
Cell Biology
Oncology
Stem cells
Immunology and Allergy
Immunology
Genetics
Cancer Research
Cardiology and Cardiovascular Medicine
Pharmacology (medical)
Radiology, Nuclear Medicine and imaging
Drug Discovery
Pharmacology

Publications

Tumor mutational burden is a determinant of immune-mediated survival in breast cancer

OncoImmunology / Jul 30, 2018

Thomas, A., Routh, E. D., Pullikuth, A., Jin, G., Su, J., Chou, J. W., Hoadley, K. A., Print, C., Knowlton, N., Black, M. A., Demaria, S., Wang, E., Bedognetti, D., Jones, W. D., Mehta, G. A., Gatza, M. L., Perou, C. M., Page, D. B., Triozzi, P., & Miller, L. D. (2018). Tumor mutational burden is a determinant of immune-mediated survival in breast cancer. OncoImmunology, 7(10), e1490854. https://doi.org/10.1080/2162402x.2018.1490854

BRG1 interacts with SOX10 to establish the melanocyte lineage and to promote differentiation

Nucleic Acids Research / Apr 20, 2017

Marathe, H. G., Watkins-Chow, D. E., Weider, M., Hoffmann, A., Mehta, G., Trivedi, A., Aras, S., Basuroy, T., Mehrotra, A., Bennett, D. C., Wegner, M., Pavan, W. J., & de la Serna, I. L. (2017). BRG1 interacts with SOX10 to establish the melanocyte lineage and to promote differentiation. Nucleic Acids Research, 45(11), 6442–6458. https://doi.org/10.1093/nar/gkx259

Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer

Breast Cancer Research and Treatment / Feb 07, 2017

Mehta, G. A., Parker, J. S., Silva, G. O., Hoadley, K. A., Perou, C. M., & Gatza, M. L. (2017). Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer. Breast Cancer Research and Treatment, 162(3), 439–450. https://doi.org/10.1007/s10549-017-4139-2

MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy

Journal of Molecular and Cellular Cardiology / Nov 01, 2015

Mehta, G., Kumarasamy, S., Wu, J., Walsh, A., Liu, L., Williams, K., Joe, B., & de la Serna, I. L. (2015). MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy. Journal of Molecular and Cellular Cardiology, 88, 101–110. https://doi.org/10.1016/j.yjmcc.2015.09.010

SWI/SNF Enzymes Promote SOX10- Mediated Activation of Myelin Gene Expression

PLoS ONE / Jul 16, 2013

Marathe, H. G., Mehta, G., Zhang, X., Datar, I., Mehrotra, A., Yeung, K. C., & de la Serna, I. L. (2013). SWI/SNF Enzymes Promote SOX10- Mediated Activation of Myelin Gene Expression. PLoS ONE, 8(7), e69037. https://doi.org/10.1371/journal.pone.0069037

Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance

Journal of Mammary Gland Biology and Neoplasia / May 09, 2019

Mehta, G. A., Khanna, P., & Gatza, M. L. (2019). Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance. Journal of Mammary Gland Biology and Neoplasia, 24(3), 213–230. https://doi.org/10.1007/s10911-019-09430-6

SWI/SNF Chromatin Remodeling Enzymes in Melanocyte Differentiation and Melanoma

Critical Reviews in Eukaryotic Gene Expression / Jan 01, 2014

Mehrotra, A., Mehta, G., Aras, S., Trivedi, A., & de la Serna, I. (2014). SWI/SNF Chromatin Remodeling Enzymes in Melanocyte Differentiation and Melanoma. Critical Reviews in Eukaryotic Gene Expression, 24(2), 151–161. https://doi.org/10.1615/critreveukaryotgeneexpr.2014007882

CPT1A and fatty acid β-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer

NAR Cancer / Jul 02, 2021

Jariwala, N., Mehta, G. A., Bhatt, V., Hussein, S., Parker, K. A., Yunus, N., Parker, J. S., Guo, J. Y., & Gatza, M. L. (2021). CPT1A and fatty acid β-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer. NAR Cancer, 3(3). https://doi.org/10.1093/narcan/zcab035

Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis

EBioMedicine / Dec 01, 2019

Karagoz, K., Mehta, G. A., Khella, C. A., Khanna, P., & Gatza, M. L. (2019). Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis. EBioMedicine, 50, 191–202. https://doi.org/10.1016/j.ebiom.2019.11.009

Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer

Journal of Personalized Medicine / Feb 19, 2021

Khella, C. A., Mehta, G. A., Mehta, R. N., & Gatza, M. L. (2021). Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer. Journal of Personalized Medicine, 11(2), 149. https://doi.org/10.3390/jpm11020149

FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036

npj Breast Cancer / May 12, 2021

Angus, S. P., Stuhlmiller, T. J., Mehta, G., Bevill, S. M., Goulet, D. R., Olivares-Quintero, J. F., East, M. P., Tanioka, M., Zawistowski, J. S., Singh, D., Sciaky, N., Chen, X., He, X., Rashid, N. U., Chollet-Hinton, L., Fan, C., Soloway, M. G., Spears, P. A., Jefferys, S., … Johnson, G. L. (2021). FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036. Npj Breast Cancer, 7(1). https://doi.org/10.1038/s41523-021-00258-0

SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2

npj Breast Cancer / Apr 09, 2021

Mehta, G. A., Angus, S. P., Khella, C. A., Tong, K., Khanna, P., Dixon, S. A. H., Verzi, M. P., Johnson, G. L., & Gatza, M. L. (2021). SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2. Npj Breast Cancer, 7(1). https://doi.org/10.1038/s41523-021-00248-2

Abstract P2-03-03: BRG1-SOX4 mediates a novel and essential signaling network that activates PI3K/Akt signaling in TNBC

Cancer Research / Feb 15, 2019

Gatza, M., Angus, S., Khella, C., Tong, K., Verzi, M., & Mehta, G. (2019). Abstract P2-03-03: BRG1-SOX4 mediates a novel and essential signaling network that activates PI3K/Akt signaling in TNBC. Cancer Research, 79(4_Supplement), P2-03-03-P2-03–03. https://doi.org/10.1158/1538-7445.sabcs18-p2-03-03

Abstract PD15-09: Sox4 and smarca4 upregulate glycolysis-driven tumor proliferation through hexokinase 2 in tnbc

Cancer Research / Feb 15, 2021

Khanna, P., Mehta, G., & Gatza, M. L. (2021). Abstract PD15-09: Sox4 and smarca4 upregulate glycolysis-driven tumor proliferation through hexokinase 2 in tnbc. Cancer Research, 81(4_Supplement), PD15-09-PD15-09. https://doi.org/10.1158/1538-7445.sabcs20-pd15-09

Abstract PO-035: SOX4 and SMARCA4 upregulate glycolysis-driven tumor proliferation through Hexokinase 2 in Triple Negative Breast Cancer

Cancer Research / Dec 01, 2020

Khanna, P., Mehta, G., Bhatt, V., Guo, J. Y., & Gatza, M. L. (2020). Abstract PO-035: SOX4 and SMARCA4 upregulate glycolysis-driven tumor proliferation through Hexokinase 2 in Triple Negative Breast Cancer. Cancer Research, 80(23_Supplement), PO-035-PO-035. https://doi.org/10.1158/1538-7445.epimetab20-po-035

Wound healing, anti-microbial and antioxidant potential of Dendrophthoe falcata (L.f) Ettingsh

Journal of Ethnopharmacology / Nov 01, 2008

Pattanayak, S. P., & Sunita, P. (2008). Wound healing, anti-microbial and antioxidant potential of Dendrophthoe falcata (L.f) Ettingsh. Journal of Ethnopharmacology, 120(2), 241–247. https://doi.org/10.1016/j.jep.2008.08.019

Education

Ph.D., Biochemistry and Cancer Biology / May, 2015

Toledo, Ohio, United States of America

University of Mumbai

M.Sc., Biotechnology / May, 2009

Mumbai

University of Mumbai

B.Sc., Biotechnology / May, 2007

Mumbai

Experience

Rutgers Cancer Institute of New Jersey

Post-Doctoral Researcher / April, 2016October, 2021

PMV Pharma

Research Scientist / May, 2022Present

WuXi Advanced Therapies

Scientist / November, 2021May, 2022

Join Gaurav on NotedSource!
Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.

Expert Institutions
NotedSource has experts from Stanford University
Expert institutions using NotedSource include Oxfort University
Experts from McGill have used NotedSource to share their expertise
University of Chicago experts have used NotedSource
MIT researchers have used NotedSource
Proudly trusted by
Microsoft uses NotedSource for academic partnerships
Johnson & Johnson academic research projects on NotedSource
ProQuest (Clarivate) uses NotedSource as their industry academia platform
Slamom consulting engages academics for research collaboration on NotedSource
Omnicom and OMG find academics on notedsource
Unilever research project have used NotedSource to engage academic experts